New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method Reply

Ugur Onsel Turk; Mustafa Arici

New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method Reply

Ugur Onsel Turk
, Mustafa Arici

Izmir Ekonomi Universitesi

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	596-597
Number of pages	2
Journal	Turk Kardiyoloji Dernegi Arsivi
Volume	49
Issue number	7
Publication status	Published - Oct 2021

Keywords

Outcomes
Edoxaban
Impact

Cite this

@article{7d5e77eb91cd4832934dc46620599566,

title = "New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method Reply",

keywords = "Outcomes, Edoxaban, Impact",

author = "Turk, \{Ugur Onsel\} and Mustafa Arici",

year = "2021",

month = oct,

language = "English",

volume = "49",

pages = "596--597",

journal = "Turk Kardiyoloji Dernegi Arsivi",

issn = "1016-5169",

publisher = "Turkish Society of Cardiology",

number = "7",

}

TY - JOUR

T1 - New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand?

T2 - An expert consensus view using the Delphi method Reply

AU - Turk, Ugur Onsel

AU - Arici, Mustafa

PY - 2021/10

Y1 - 2021/10

KW - Outcomes

KW - Edoxaban

KW - Impact

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000707718900017&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Letter

SN - 1016-5169

VL - 49

SP - 596

EP - 597

JO - Turk Kardiyoloji Dernegi Arsivi

JF - Turk Kardiyoloji Dernegi Arsivi

IS - 7

ER -

New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method Reply

Keywords

Other files and links

Cite this